Study of Enfuvirtide in HIV-Positive Subjects

Completed · Phase 1

Conditions studied: HIV Infections, AIDS

In brief

A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.

Key facts

Study ID

NCT00086710

Run by

Trimeris

People needed

26

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• SFBC — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.